FTC sues main pharmacy advantage managers about insulin price ranges The company introduced motion in opposition to Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of lifestyle-preserving insulin medicine. Pay attention to the report 10 min This audio is car-generated. https://kethek.com/